Schistosoma Mekongi

Schistosoma Mekongi General Information

Bilharzia is a more widely spread medical term for a quite common parasitic clinical illness known as Schistosomiasis. The presence of this medical disorder is known to be caused by some types of trematodes (pathogens) that belong to the Schistosoma genus. Humans are known to be at a high risk of developing infections due to 4 of the most common species of Schistoma trematodes. They are: Schistosoma Japonicum, Schistosoma Mekongi, S. mansoni (these three are known to affect the patient’s intestines, causing an intestinal form of Schistomiasis), and also S. Haematobium (which causes the urinary form of Schistomiasis).

The parasite that is known to cause S. Mekongi is known to generally affect rodents and / or dogs. Its presence has been reported in the lower region of the basin of the Mekong River since 1957. Other parts of the world in which this worm can be easily found include: Laos, Thailand, Cambodia, and so on. The adult representatives of the worms (pathogens) situate themselves in the branches of the patient’s intestinal blood vessels that are known to open into the organism’s portal vein and mesenteric vein. Although the eggs that are laid by this type of worm are known to be very similar to those of S. Japonicum, they are smaller than the latter’s. They are of a round shape. They present a later spine that can be somewhat challenging to detect, as it is near one of the end’s of the parasite’s body. If you want to know further details regarding this medical condition Schistosoma Mekongi you should contact your personal health care provider. He or she will be more than happy to give you adequate answers to all of your potential questions.

Schistosoma Mekongi Symptoms

After studying this infectious medical disorder, scientists have been able to determine certain clinical manifestations (symptoms) that are known to be widely associated with the presence an infection with the Schistosoma Mekongi parasite. Most clinical cases in which the individual had been diagnosed with a light infection with this parasite did not present any specific (unpleasant) symptoms – in other words, the light form of this infectious disorder is known to be asymptomatic. However, in the case of clinical patients who present ectopic localizations due to this parasite, the presence of several unpleasant (severe) symptoms is possible. Neurological lesions and other life-threatening condition are possible. The presence of a disorder known as hepatosplenomegaly, accompanied by diverted circulation of blood may determine the appearance of severe (dangerous) infectious clinical disorders.

The most common way of accurately diagnosing the presence of this medical disorder is by looking for the presence of eggs of the parasite in the patient’s urine and / or stool. If the presence of this infectious condition is suspected by the patient’s health care provider, the individual ought to undergo immediate stool examination. This type of clinical evaluation may be performed on a common smear (it requires 1 to 2 mg of the patient’s fecal waste). Another way to effectively identify the presence of egg output in the patient’s stool may be performed through the Kato-Katz technique (that requires the presence of 20 to 50 g of fecal waste).

Schistosoma Mekongi eggs are also sometimes found in the individual’s urine. The detection of their presence will be highly enhanced through a detailed examination of the sediment that has remained after the sample has undergone centrifugation.

Schistosoma Mekongi Treatment

An individual who is following a treatment trial with this medication (in order to deal with his or her disorder – for example, Schistosoma Mekongi) should employ extra caution (attention) while driving or performing any type of life-threatening, complicated and / or dangerous activities, as the intake of this medical remedy is known to trigger symptoms such as dizziness. Each dose of this medicine should be accompanied with a glass of liquid. It is recommended for each patient to try to take his or her doses of this drug with food. It is strictly forbidden for any patient who is following a dosing schedule with this medication to chew and / or crush the tablets of Praziquantel. It is important for all individuals to try and swallow them whole, as they have been especially designed to gradually release their active components (ingredients) in the patient’s organism. For this reason, any severe damage that is done to the capsule of Praziquantel before it is ingested will affect the medicine’s effectiveness against Schistosoma Mekongi.

This medical remedy is a category B FDA pregnancy medication. The use of this medical drug has not been yet approved for children who are under 4 years of age. A patient who is following a prolonged therapy with Praziquantel in order to effectively manage his or her Schistosoma Mekongi may experience some of the side effects of this medicine. The most common of them include: abdominal discomfort, stomach upset, fever, hives or other symptoms that may be triggered by the presence of an allergic reaction to one or more of this drug’s components.